Soleil Securities reiterates a 'Buy' rating on Ardea Biosciences (Nasdaq: RDEA), price target $27.

Soleil analyst says, "Efficacy and tolerability ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE